CYBB and metabolic syndrome: Even though there is no study addressing such interaction in platelets from MetS patients, it is plausible to infer that PDI might also regulate Nox2 activity in these cells, further contributing for OxS-driven NOS uncoupling, thromboxane generation as well as insulin resistance.